An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism the women's genome health study

Circulation: Cardiovascular Genetics

Volumn 2, Issue 1, 2009, Pages 57-62

  Zee, Robert Y L ^a   Glynn, Robert J ^a   Cheng, Suzanne ^b   Steiner, Lori ^b   Rose, Lynda ^a   Ridker, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

Candidate genes; Genetics; Polymorphisms; Risk factors; VTE

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; PROTHROMBIN; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEMOSTASIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THROMBOSIS; VENOUS THROMBOEMBOLISM; GENETIC POLYMORPHISM; GENETICS; RISK FACTOR;

COHORT STUDIES; FACTOR V; FACTOR VII; FEMALE; GENOTYPE; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-1BETA; POLYMORPHISM, GENETIC; PROTHROMBIN; RISK FACTORS; THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 69249230071     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.108.801969     Document Type: Article

References (33)

1. Burstein SA, Peng J, Friese P, Wolf RF, Harrison P, Downs T, Hamilton K, Comp P, Dale GL. Cytokine-induced alteration of platelet and hemostatic function. Stem Cells. 1996; 14 (suppl 1) : 154-162. (Pubitemid 126687204)
2. Downing LJ, Strieter RM, Kadell AM, Wilke CA, Austin JC, Hare BD, Burdick MD, Greenfield LJ, Wakefield TW. IL-10 regulates thrombusinduced vein wall inflammation and thrombosis. J Immunol. 1998; 161: 1471-1476.
3. Wakefield TW, Strieter RM, Prince MR, Downing LJ, Greenfield LJ. Pathogenesis of venous thrombosis: a new insight. Cardiovasc Surg. 1997; 5: 6-15. (Pubitemid 27219718)
4. Reitsma PH, Rosendaal FR. Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost. 2004; 2: 619-622.
5. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005; 294: 56-65. (Pubitemid 41002839)
6. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005; 352: 1293-1304. (Pubitemid 41002838)
7. Ridker PM, Chasman DI, Zee RY, Parker A, Rose L, Cook NR, Buring JE. Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25, 000 initially healthy American women. Clin Chem. 2008; 54: 249-255. (Pubitemid 351302617)
8. Glynn RJ, Ridker PM, Goldhaber SZ, Buring JE. Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial. Ann Intern Med. 2007; 147: 525-533. (Pubitemid 351664499)
9. Glynn RJ, Ridker PM, Goldhaber SZ, Zee RY, Buring JE. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Circulation. 2007; 116: 1497-1503.
10. Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, Chen JJ, Pullinger CR, Malloy MJ, Siest G, Kane JP. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res. 1999; 9: 936-949. (Pubitemid 29525202)
11. Zee RY, Cook NR, Cheng S, Erlich HA, Lindpaintner K, Ridker PM. Polymorphism in the beta2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: a multilocus, population-based, prospective genetic analysis. Circulation. 2006; 113: 2193-2200. (Pubitemid 43755142)
12. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995; 57: 289-300.
13. Smith NL, Hindorff LA, Heckbert SR, Lemaitre RN, Marciante KD, Rice K, Lumley T, Bis JC, Wiggins KL, Rosendaal FR, Psaty BM. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA. 2007; 297: 489-498. (Pubitemid 46220804)
14. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984; 160: 618-623.
15. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr. Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion. Am J Pathol. 1985; 121: 394-403.
16. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest. 1985; 76: 2003-2011.
17. Klein NJ, Shennan GI, Heyderman RS, Levin M. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils. J Cell Sci. 1992; 102 (pt 4) : 821-832.
18. Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res. 2004; 114: 321-327.
19. Fox EA, Kahn SR. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost. 2005; 94: 362-365. (Pubitemid 41122491)
20. Pieroni F, Lourenco DM, Morelli VM, Maffei FH, Zago MA, Franco RF. Cytokine gene variants and venous thrombotic risk in the BRATROS (Brazilian Thrombosis Study). Thromb Res. 2007; 120: 221-229. (Pubitemid 46754420)
21. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy RP, Aleksic N, Folsom AR. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med. 2002; 113: 636-642. (Pubitemid 36015799)
22. Vormittag R, Hsieh K, Kaider A, Minar E, Bialonczyk C, Hirschl M, Mannhalter C, Pabinger I. Interleukin-6 and interleukin-6 promoter polymorphism (-174) G>C in patients with spontaneous venous thromboembolism. Thromb Haemost. 2006; 95: 802-806. (Pubitemid 44301137)
23. Vormittag R, Funk M, Mannhalter C, Schonauer V, Vukovich T, Minar E, Bialonczyk C, Hirschl M, Pabinger I. C-reactive protein 3' UTR + 1444C>T polymorphism in patients with spontaneous venous thromboembolism. Atherosclerosis. 2006; 188: 406-411. (Pubitemid 44301137)
24. Folsom AR, Cushman M, Heckbert SR, Ohira T, Rasmussen-Torvik L, Tsai MY. Factor VII coagulant activity, factor VII - 670A/C and - 402G/A polymorphisms, and risk of venous thromboembolism. J Thromb Haemost. 2007; 5: 1674-1678.
25. Bezemer ID, Bare LA, Doggen CJ, Arellano AR, Tong C, Rowland CM, Catanese J, Young BA, Reitsma PH, Devlin JJ, Rosendaal FR. Gene variants associated with deep vein thrombosis. JAMA. 2008; 299: 1306-1314.
26. Vaya A, Mira Y, Mateo J, Falco C, Villa P, Estelles A, Corella D, Fontcuberta J, Aznar J. Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk. Thromb Haemost. 2003; 89: 452-457.
27. Tormene D, De Stefano V, Grandone E, Za T, Perlati M, Rossi E, Margaglione M, Simioni P. The G20210A prothrombin variant and the risk of venous thromboembolism or fetal loss in pregnant women: a family study. J Thromb Haemost. 2007; 5: 2193-2196.
28. Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med. 2000; 342: 374-380. (Pubitemid 30084535)
29. De Stefano V, Rossi E, Paciaroni K, D'Orazio A, Cina G, Marchitelli E, Pepe R, Leone G. Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene. Haematologica. 2003; 88: 61-66.
30. Couturaud F, Kearon C, Leroyer C, Mercier B, Abgrall JF, Le Gal G, Lacut K, Oger E, Bressollette L, Ferec C, Lamure M, Mottier D. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. Thromb Haemost. 2006; 96: 744-749.
31. Martinelli I, Battaglioli T, De Stefano V, Tormene D, Valdre L, Grandone E, Tosetto A, Mannucci PM. The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A. J Thromb Haemost. 2008; 6: 494-498.
32. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005; 162: 975-982.
33. Rose-John S, Waetzig GH, Scheller J, Grotzinger J, Seegert D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets. 2007; 11: 613-624.